Gene therapy: the tailor-made treatment

June 28, 2006
Research and Development drug development, gene therapy

 At the risk of boring my audience, I really can't help beginning with yet another attack of nostalgia ,or rather …

Calling up reinforcements

June 28, 2006
Business Services interim management, recruitment

In the pharmaceutical industry outsourcing has never enjoyed greater popularity and all the indications are that this trend is set …

New drug for treatment-resistant HIV approved

June 28, 2006
Sales and Marketing

Prezista, a new drug for patients who have treatment-resistant HIV, has been approved in the US.The treatment from Johnson & …

Novartis to market new vaccine for Japanese encephalitis

June 28, 2006
Sales and Marketing

Novartis has licensed the marketing rights to a phase III vaccine from Intercell for Japanese encephalitis virus infections. The vaccine …

J&J buys Pfizer consumer health division for $16 billion

June 27, 2006
Sales and Marketing

Healthcare conglomerate Johnson & Johnson is to buy Pfizer's consumer health division for more than $16 billion, a move which …

Novartis buys Manchester-based biotech and superbug drugs

June 21, 2006
Research and Development

UK biotech NeuTec is to be acquired by Swiss pharma giant Novartis which says the company's two anti-infective drug candidates …

Schering-Plough named in top 50 best places to work in UK

June 20, 2006
Business Services careers

Schering-Plough UK has been named as one of best places to work in the country, based on a survey of …

Study shows Inegy scores over its rival Crestor

June 19, 2006
Sales and Marketing

A head-to-head study on the combination cholesterol-lowering drug, Inegy, has shown that it could be more effective than one of …

Bayer clinches Schering purchase

June 16, 2006
Sales and Marketing

The tussle between Merck KGaA and Bayer for control of fellow German pharma company Schering has been settled, with Merck …

Ringing the changes in pharmaceutical sales

June 16, 2006
Sales and Marketing sales, strategy

Every business and every market is unique, but there is a huge expanse of common ground when it comes to …

Galvus could offer hope to difficult-to-treat diabetes patients

June 16, 2006
Sales and Marketing

Galvus, a new antidiabetic drug that appears to limit the weight gain and fluid retention which often occurs with other …

GPs launch scathing attack on health service reforms

June 16, 2006

Government reforms and targets for the health service have come under a scathing and comprehensive attack from general practitioners, who …

Allergan chooses UK for research base

June 16, 2006
Allergan

US specialist pharmaceutical company Allergan has opened its new European research and development operations in Marlow in Buckinghamshire.Allergan is the …

Switching scripts: the impact of NHS reforms

June 15, 2006
Sales and Marketing NHS, healthcare, sales, strategy

During 2006/7, the NHS in England will see an unprecedented level of change within primary care with the reconfiguration of …

Top Pharmaceutical Employers

June 14, 2006
careers

AstraZenecaAstraZeneca, the UK's second biggest home-grown big pharma company has continued to thrive over the last few years, despite some …

Cancer vaccine continues to show encouraging results

June 14, 2006
Research and Development

Oxford BioMedica, the UK gene therapy specialist, has reported encouraging results from five phase II studies of TroVax, its leading …

Combination pill cuts heart attacks

June 13, 2006
Sales and Marketing

New data on Pfizer's combination pill Caduet show it can cut the number of heart attacks and strokes in at-risk …

Blockbuster potential for diabetes vision drug

June 13, 2006
Research and Development, Sales and Marketing

Lilly says new phase III data on its drug Arxxant shows it can stop diabetes patients losing their sight.Data from …

True scale of NHS deficits ‘masked’ says think tank

June 9, 2006

Figures showing the NHS with debts of 512 million pounds are masking the true extent of the crisis, according to …

Relief for campaigners as NICE approves Herceptin

June 9, 2006

Breast cancer drug campaigners have breathed a sigh of relief after NICE said Herceptin should be used to treat women …

The Gateway to Local Adoption Series

Latest content